[Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
For better control of tuberculosis World Heath Organization has prepared directly observed treatment short-course strategy (DOTS). The number of countries implementing the DOTS has increased bringing the total to 180. TB mortality decreased in western countries but it is very important problem in Africa and Asia. Multidrug-resistant tuberculosis, defined as resistance of M. tuberculosis to at least INH and RMP is especially worrisome because of its potential impact on the control of TB. MDRTB has been reported in most parts of the world but especially in Eastern Europe and in the countries where TB and HIV coinfection is endemic. TB is one of the most frequent opportunistic infections among HIV-infected individuals, and often the first manifestation of HIV disease.
Zielonka
Tadeusz M
TM
Akademia Medyczna w Warszawie, Katedra i Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii. zielonka@amwaw.edu.pl
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000382:microbiology; D000349:Africa / Q000453:epidemiology; D001208:Asia / Q000453:epidemiology; D001500:BCG Vaccine / Q000627:therapeutic use; D015897:Comorbidity; D023801:Directly Observed Therapy; D005060:Europe / Q000453:epidemiology; D014943:Global Health; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D011044:Poland / Q000453:epidemiology; D015995:Prevalence; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000401:mortality*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000401:mortality*
D001500:BCG Vaccine